ELITE 2021 Marketing Team GLP-1 Consumer Marketing Team & Omni-Channel Media Team

GLP-1 Consumer Marketing Team & Omni-Channel Media Team

Novo Nordisk

Agency Partners: Cult Health, Brainworks, InStep Health

Expanding and Enhancing a Pharmacy Program

In 2020, it became clear to the Novo Nordisk GLP-1 Franchise Marketing Team that their planned mid-year DTC campaign launch of Rybelsus—one of the most significant launches in the company’s history—would need to be delayed. Among many other things, they needed to re-shoot the TV ad, rejigger every DTC campaign element, and reassess the entire marketing plan. On top of this, the team was also responsible for Ozempic, another key brand that had its marketing plans upended by the COVID-19 pandemic. But they turned what could have been a calamitous situation into a successful Rybelsus launch and a seamless continuation of key Ozempic marketing strategies.

Partnering with InStep Health, they made modifications to optimize the Ozempic pharmacy program (including adding a QR code for no-touch access to brand information and modifying the geographic footprint to include areas not as significantly impacted by the pandemic) and moved the Rybelsus effort to later in the year. Furthermore, they worked together to expand the portfolio of marketing capabilities for the brands to include the ability to message patients and providers at the HCP office and augment other digital capabilities to create a fuller marketing solution platform. The two companies set up a series of ongoing weekly meetings to hammer out the details, develop the creative, gain medical-legal approval on all the elements, and run a pilot test for the new offerings.

Ozempic’s resulting pilot campaign—a strategic combination of pharmacy displays, HCP education-focused office tactics, and targeted patient digital—drove conversion among targeted HCPs, delivered a high level of patient engagement, and generated incremental Rx lift. As for Rybelsus, the ongoing pharmacy program is displaying solid results to date as well, on track to deliver double-digit ROI and a significant lift in prescription volume as measured via test vs. control matched panel research.


You May Also Like

ELITE 2018 Strategist Arvashni Seeripat of Novartis

Arvashni Seeripat Director, Gilenya® Consumer & Patient Services Marketing Novartis Achieving Localized Success “Gilenya ...

Movers and Shakers September 2021

J&J Transitions to New CEO Johnson & Johnson announced that Alex Gorsky, CEO for ...

PM360 2021 Trailblazer Awards Consumer Website/Online Initiative Gold Winner Kala Pharmaceuticals and QBFox Healthcomm

EYSUVIS, “MYEYSUVIS” (Kala Pharmaceuticals, QBFox Healthcomm) The innovative Dry Eye Disease (DED) campaign from ...